Arg214

Site Information
VPELFANrGGRQGLG SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 15494605

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	testicular cancer ( 3 )
Relevant cell line - cell type - tissue:	F9 (testicular) ( 3 ) , PYS-2 (epithelial) ( 2 )

References
1	Zhou J (2010) CST Curation Set: 9110; Year: 2010; Biosample/Treatment: cell line, ES J1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
2	Zhou J (2010) CST Curation Set: 9115; Year: 2010; Biosample/Treatment: cell line, PY2/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
3	Zhou J (2010) CST Curation Set: 9111; Year: 2010; Biosample/Treatment: cell line, F9/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info